Boston Scientific’s facility in Galway. The company is set to expand its Cork facility with a €30 million investment. Photograph: Joe O’Shaughnessy

Boston Scientific is to invest €30 million in its Cork facility, creating more than 70 jobs over the next three years.

The investment will boost the development of its minimally invasive medical technologies used in the treatment of patients with cancer and peripheral arterial diseases, and fund new technology capabilities at the Cork facility.

The jobs will be in engineering and production, growing the current workforce at the site from more than 1,200 people.

Boston Scientific is the largest life sciences employer in Ireland, employing more than 6,000 people at three sites Galway, Clonmel and Cork. The company established its Irish operations in 1994.

“We are delighted to be adding new quality, engineering and production capabilities to our Cork facility and contributing further to the strong MedTech sector in the region,” said Sean Gayer, vice president operations at Boston Scientific, Cork.

The news of the investment was welcomed by Tánaiste Leo Varadkar. “This investment will allow the company to grow and develop its world leading technologies and ensure that it continues helping to improve and save lives,” he said. “Ireland is globally recognised as a centre of excellence for the Life Sciences and this investment is a real vote of confidence in us and our capacity. I wish the team the very best with their plans.”

The investment is being supported by IDA Ireland. “Boston Scientific has had a strong presence in the Cork business community for nearly 25 years.” said Martin Shanahan, chief executive of IDA Ireland. “As the company grows and expands into more therapeutic areas through internal RD&I and acquisitions its continued investment in ongoing operations and highly skilled local talent is encouraging. This expansion is further evidence of the southwest region’s thriving MedTech cluster.”